Phase 4Active, not recruitingHealthspan endpoint
GLP-1s to Enhance Lasting Optimal Weight (GLOW)
Tirzepatide in Obesity
Wake Forest University Health Sciences · 40 enrolled · NCT06861439 · updated 2 Oct 2026
From ClinicalTrials.gov
Trials of drugs and interventions aimed at aging, of age-related conditions through aging biology, and of healthspan itself: new registrations, status changes and first results.
Phase 4Active, not recruitingHealthspan endpoint
Tirzepatide in Obesity
Wake Forest University Health Sciences · 40 enrolled · NCT06861439 · updated 2 Oct 2026